Request Deal Involvement

New Enterprise Associates led a $70m series C round in Inversago Pharma.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

White & Case

legal advisors

White & Case

Osler Hoskin & Harcourt

legal advisors

Osler Hoskin & Harcourt

or

Principals

INVERSAGO PHARMA

target

INVERSAGO PHARMA

NEW ENTERPRISE ASSOCIATES (NEA)

bidder

NEW ENTERPRISE ASSOCIATES (NEA)

ADMARE BIOINNOVATIONS

bidder

ADMARE BIOINNOVATIONS

AMORCHEM

bidder

AMORCHEM

FORBION CAPITAL PARTNERS

bidder

FORBION CAPITAL PARTNERS

AMGEN VENTURES

bidder

AMGEN VENTURES

FONDS DE SOLIDARITÉ FTQ

bidder

FONDS DE SOLIDARITÉ FTQ

GENESYS CAPITAL

bidder

GENESYS CAPITAL

JDRF T1D FUND

bidder

JDRF T1D FUND

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - New Enterprise Associates led a $70m series C round in Inversago Pharma.